Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pseudouridine synthase 1 promotes hepatocellular carcinoma through mRNA pseudouridylation to enhance the translation of oncogenic mRNAs
Yanxia Hu, Li‐Ting Diao, Ya‐Rui Hou, et al.
Hepatology (2023) Vol. 80, Iss. 5, pp. 1058-1073
Closed Access | Times Cited: 13

Showing 13 citing articles:

Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
Shiheng Jia, Xue Yu, Na Deng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
PUS1 facilitates cell migration in clear cell renal cell carcinoma through the promotion of mRNA pseudouridylation and the stabilization of the SMOX gene
Yao Chen, Sujing Zhang, Bowen Zeng, et al.
Cellular Signalling (2025) Vol. 130, pp. 111700-111700
Open Access
Transcriptomic profile of RNA pseudouridine modification as a biomarker for cellular senescence associated with survival outcomes in colorectal cancer
Yingguo Gan, Ze Yuan, Jingrong Weng, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Pseudouridine synthase 1 promotes progression of hepatocellular carcinoma via mTOR and MYC signaling pathways
Lixia Chen, Yonghuang Tan, Weinan Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Unveiling the clinical significance of RNA pseudouridine in colorectal cancer
Jiehua Li, Xuanfei Li, Xiaole Zhao, et al.
Science China Life Sciences (2025)
Closed Access
RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond
Yuan Ding, Cuicui Liu, Ke‐Da Yu
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Current Advancements in Serum Protein Biomarkers for Hepatitis B Virus‐Associated Hepatocyte Remodeling and Hepatocellular Carcinoma
Adane Adugna, Gashaw Azanaw Amare, Mohammed Jemal
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
TRUB1 is a novel biomarker for promoting malignancy in colorectal cancer via NFκB signaling
Yingzhao Wang, Yonghuang Tan, Tian-hao Zhang, et al.
Gastroenterology report (2025) Vol. 13
Open Access
Dysregulated ribosome quality control in human diseases
Tom McGirr, Okan Onar, Seyed Mehdi Jafarnejad
FEBS Journal (2024)
Open Access | Times Cited: 2
Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva
Noah J. Daniels, Courtney E. Hershberger, Matthew Kerosky, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10144-10144
Open Access | Times Cited: 2
Significant roles of RNA 5-methylcytosine methylation in cancer
Ning Lou, Xinyu Gu, Li Fu, et al.
Cellular Signalling (2024) Vol. 126, pp. 111529-111529
Closed Access
Transcriptomic analysis reveals prognostic molecular subtype and candidate risk model for pseudouridylation- related genes in hepatocellular carcinoma
Chenlu Lan, Yongguang Wei, Huasheng Huang, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top